FNY Partners Fund’s Biocept, Inc. BIOC Stock Holding History

FNY Partners Fund’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$21K	–	1256
2017 Q1	$21K	Buy	+1	New	+$17K	﹤0.01%	945

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FNY Partners Fund's BIOC Position: Q2 2017 in Review

FNY Partners Fund sold out of Biocept, Inc. (BIOC) in Q2 2017, closing a stake of 1 share — an estimated $21K sold.

FNY Partners Fund first reported a position in BIOC in Q1 2017 and held it in 1 quarter. The position peaked at $21K in Q1 2017. 15 funds tracked by Wall St. Rank hold BIOC as of Q2 2017.

FNY Partners Fund reported no remaining Biocept, Inc. position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 1 Biocept, Inc. share in Q2 2017, an estimated $21K.
FNY Partners Fund first reported a position in Biocept, Inc. in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Biocept, Inc. position peaked at $21K in Q1 2017.
15 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.